Johnson & Johnson Creates Trial Drug Bioethics Panel
Johnson & Johnson has appointed a leading bioethicist to head a panel to determine how to handle requests from people who are critically ill and want access to promising drugs before they are approved. Full Story
/https://static.texastribune.org/media/images/2013/06/13/PillsOnTable.jpg)